NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) — Scott+Scott Attorneys LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, reminds investors that it continues to investigate whether certain directors and officers of Abbott Laboratories (“Abbott”) (NYSE: ABT) are fulfilling their fiduciary duties to Abbott and its shareholders. If you are an Abbott shareholder, please contact Attorney Joe Pettigrew of Scott+Scott at (844) 818-6982 or for more information [email protected].

Scott+Scott is investigating whether members of Abbott’s board of directors or senior management failed to manage Abbott in an acceptable manner in breach of their fiduciary duty to Abbott and whether harm was caused to Abbott and its stockholders.

On May 16, 2022, the United States filed a lawsuit and proposed a consent injunction against Abbott alleging that Abbott manufactured powdered infant formula under conditions and practices that did not comply with regulations designed to ensure the quality and safety of infant formula.

What you can do

If you are an Abbott shareholder, you may have legal claims against Abbott’s directors and officers. If you would like to discuss this investigation or have any questions about this notice or your legal rights, please call Attorney Joe Pettigrew toll free at (844) 818-6982 or [email protected].

About Scott+Scott Lawyers LLP

Scott+Scott has extensive experience prosecuting major securities, antitrust and consumer lawsuits in the United States. The firm represents pension plans, endowments, individuals and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California and Ohio.

lawyer advertising

CONTACT:
Joe Pettigrew
Scott+Scott Attorneys LLP
600 W. Broadway, Suite 3300, San Diego, CA 92101
(844) 818-6982
[email protected]